| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.8M | -10.3% | +153.4% |
| Cost of Revenue | $3.4M | — | +101.1% |
| Gross Profit | $1.4M | +75.8% | +562.1% |
| R&D Expense | $9K | — | — |
| SG&A Expense | $1.7M | — | +60.5% |
| Operating Income | -$353K | +52.2% | +59.9% |
| Pre-tax Income | -$638K | — | +33.1% |
| Income Tax | $1K | — | -93.8% |
| Net Income | -$639K | -491.7% | +34.1% |
| EPS (Basic) | -$0.13 | +23.5% | +51.9% |
| EPS (Diluted) | -$0.13 | +23.5% | +51.9% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $762K | — | — |
| Accounts Receivable | $3.2M | -47.4% | — |
| Inventory | $1.8M | — | — |
| Current Assets | $6.2M | -23.7% | — |
| Total Assets | $7.7M | -20.1% | — |
| Current Liabilities | $10.6M | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | — |
| Investing Cash Flow | $250K | — | — |
| Financing Cash Flow | $1.8M | — | — |
| Long-term Debt | $4.2M | — | — |
| Total Liabilities | $14.1M | — | — |
| Stockholders' Equity | -$6.4M | -31.9% | -87.1% |